Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

Catching up with the 2024 Poster prize candidates

Original source

Catching up with the 2024 Poster prize candidatesMotor Neurone Disease Association (UK) · 4 March 2026 (opens in a new tab)

Related topics

Three researchers who were shortlisted for poster prizes in 2024 have continued developing their MND research and returned to the Symposium as judges. Their projects include studying genetic factors linked to C9orf72-related MND, searching for protein biomarkers, and investigating TDP-43 changes in brain cells.

Why this matters

The work may improve understanding of why MND develops differently between people, support earlier detection research, and identify disease mechanisms for future study. These are ongoing research projects, not treatments, and the update does not show a current benefit for people living with MND.

Limitations and context

This is an organisational blog describing researchers’ projects and progress, not a primary research paper. The source does not provide study sizes, detailed results, peer-review information, or evidence that any proposed biomarker, genetic finding, or protective pathway works in clinical practice. Further research would be needed to establish whether these approaches improve diagnosis, monitoring, or treatment.

Summarised by Compass 9 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?